Medexus Pharmaceuticals Reports Operating and Financial Results for the First Quarter of Fiscal 2020

Ads

You May Also Like

Replimune to Present at Two Upcoming Investor Conferences

WOBURN, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a ...

VIFOR PHARMA ISSUES INAUGURAL CHF 465 MILLION BOND

Vifor Pharma today announced the launch of an inaugural Swiss Franc straight bond in ...